Expanding SNOMED-CT through Spanish Drug Summaries of Product Characteristics

Calleja Ibáñez, Pablo and García Castro, Raúl and Aguado de Cea, Guadalupe and Gómez-Pérez, A. (2017). Expanding SNOMED-CT through Spanish Drug Summaries of Product Characteristics. In: "9th International Conference on Knowledge Capture (K-CAP 2017)", 04-06 Dic 2017, Austin, Texas. ISBN 978-1-4503-5553-7. pp. 200-207. https://doi.org/10.1145/3148011.3148028.

Description

Title: Expanding SNOMED-CT through Spanish Drug Summaries of Product Characteristics
Author/s:
  • Calleja Ibáñez, Pablo
  • García Castro, Raúl
  • Aguado de Cea, Guadalupe
  • Gómez-Pérez, A.
Item Type: Presentation at Congress or Conference (Article)
Event Title: 9th International Conference on Knowledge Capture (K-CAP 2017)
Event Dates: 04-06 Dic 2017
Event Location: Austin, Texas
Title of Book: Proceedings of the Knowledge Capture Conference
Date: 2017
ISBN: 978-1-4503-5553-7
Volume: 1
Subjects:
Freetext Keywords: SNOMED-CT; Named entity recognition; Mapping; Extension; Role
Faculty: E.T.S. de Ingenieros Informáticos (UPM)
Department: Inteligencia Artificial
Creative Commons Licenses: Recognition - No derivative works - Non commercial

Full text

[img]
Preview
PDF - Requires a PDF viewer, such as GSview, Xpdf or Adobe Acrobat Reader
Download (898kB) | Preview

Abstract

Terminologies in the biomedical field are one of the main resources used in the clinical practice. Keeping them up-to-date to meet realworld use cases is a critical operation that even in the case of well maintained terminologies such as SNOMED-CT involves much effort from domain experts. Pharmacological products or drugs are constantly being approved and made available in the market and their clinical information should be also updated in terminologies. Each new drug is provided with its Summary of Product Characteristics (SPC), a document in natural language that contains its essential information. This paper proposes a method for populating the Spanish extension of SNOMED-CT with drug names using SPCs and representing their clinical data sections in the terminology. More precisely, the method has been applied to the therapeutic indication and the adverse reaction sections, in which disease names are recognized as named entities in the document and mapped to the terminology. The relations between the drug name and the mapped entities are also represented in the terminology based on the specific roles that they have in the document.

Funding Projects

TypeCodeAcronymLeaderTitle
Government of SpainTIN2016-78011-C4-4UnspecifiedUniversidad Politécnica de MadridDATOS 4.0: RETOS Y SOLUCIONES - UPM

More information

Item ID: 50225
DC Identifier: http://oa.upm.es/50225/
OAI Identifier: oai:oa.upm.es:50225
DOI: 10.1145/3148011.3148028
Official URL: https://dl.acm.org/citation.cfm?id=3148011
Deposited by: Memoria Investigacion
Deposited on: 27 Mar 2019 12:34
Last Modified: 03 May 2019 08:20
  • Logo InvestigaM (UPM)
  • Logo GEOUP4
  • Logo Open Access
  • Open Access
  • Logo Sherpa/Romeo
    Check whether the anglo-saxon journal in which you have published an article allows you to also publish it under open access.
  • Logo Dulcinea
    Check whether the spanish journal in which you have published an article allows you to also publish it under open access.
  • Logo de Recolecta
  • Logo del Observatorio I+D+i UPM
  • Logo de OpenCourseWare UPM